Steroid Dependent Nephrotic Syndrome (SDNS) and Frequent Relapse Nephrotic Syndrome (FRNS) management could involve a severe degree of steroid toxicity. Rituximab (RTX), an anti-CD20 monoclonal antibody, appears to have beneficial effects in these groups of patients.
No takes yet. Share an insight, caveat, or question.
Loreti et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: